83 related articles for article (PubMed ID: 10397262)
1. The human p53 negative regulatory domain mediates inhibition of reporter gene transactivation in yeast lacking thioredoxin reductase.
Merrill GF; Dowell P; Pearson GD
Cancer Res; 1999 Jul; 59(13):3175-9. PubMed ID: 10397262
[TBL] [Abstract][Full Text] [Related]
2. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
3. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.
Iwabuchi K; Li B; Bartel P; Fields S
Oncogene; 1993 Jun; 8(6):1693-6. PubMed ID: 8502489
[TBL] [Abstract][Full Text] [Related]
4. Reporter gene transactivation by human p53 is inhibited in thioredoxin reductase null yeast by a mechanism associated with thioredoxin oxidation and independent of changes in the redox state of glutathione.
Merwin JR; Mustacich DJ; Muller EG; Pearson GD; Merrill GF
Carcinogenesis; 2002 Oct; 23(10):1609-15. PubMed ID: 12376468
[TBL] [Abstract][Full Text] [Related]
5. Effect of thioredoxin deletion and p53 cysteine replacement on human p53 activity in wild-type and thioredoxin reductase null yeast.
Stoner CS; Pearson GD; Koç A; Merwin JR; Lopez NI; Merrill GF
Biochemistry; 2009 Sep; 48(38):9156-69. PubMed ID: 19681600
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of the one-carbon metabolism regulon in Saccharomyces cerevisiae by Bas1p.
Subramanian M; Qiao WB; Khanam N; Wilkins O; Der SD; Lalich JD; Bognar AL
Mol Microbiol; 2005 Jul; 57(1):53-69. PubMed ID: 15948949
[TBL] [Abstract][Full Text] [Related]
7. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
8. Reporter gene regulation in Saccharomyces cerevisiae by the human p53 tumor suppressor protein.
Bitter GA; Schaeffer TN; Ellison AR
J Mol Microbiol Biotechnol; 2002 Nov; 4(6):539-50. PubMed ID: 12432954
[TBL] [Abstract][Full Text] [Related]
9. Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.
Benoit V; Hellin AC; Huygen S; Gielen J; Bours V; Merville MP
Oncogene; 2000 Sep; 19(41):4787-94. PubMed ID: 11032029
[TBL] [Abstract][Full Text] [Related]
10. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
Di Como CJ; Prives C
Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the Saccharomyces cerevisiae TRR1 gene encoding thioredoxin reductase inhibits p53-dependent reporter gene expression.
Pearson GD; Merrill GF
J Biol Chem; 1998 Mar; 273(10):5431-4. PubMed ID: 9488661
[TBL] [Abstract][Full Text] [Related]
12. Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription.
Miller CW; Chumakov A; Said J; Chen DL; Aslo A; Koeffler HP
Oncogene; 1993 Jul; 8(7):1815-24. PubMed ID: 8510927
[TBL] [Abstract][Full Text] [Related]
13. Establish a recombinant yeast detection system to study the effect of MIP on transactivation function of hMafF in US2-driven gene transcription.
Ye X; Shi Y; Huo K; Chen D
J Microbiol Methods; 2009 Oct; 79(1):96-100. PubMed ID: 19723544
[TBL] [Abstract][Full Text] [Related]
14. Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity.
Seemann S; Hainaut P
Oncogene; 2005 Jun; 24(24):3853-63. PubMed ID: 15824742
[TBL] [Abstract][Full Text] [Related]
15. Evidence for intriguingly complex transcription of human thioredoxin reductase 1.
Rundlöf AK; Janard M; Miranda-Vizuete A; Arnér ES
Free Radic Biol Med; 2004 Mar; 36(5):641-56. PubMed ID: 14980707
[TBL] [Abstract][Full Text] [Related]
16. p53 mutated in the transactivation domain retains regulatory functions in homology-directed double-strand break repair.
Boehden GS; Akyüz N; Roemer K; Wiesmüller L
Oncogene; 2003 Jun; 22(26):4111-7. PubMed ID: 12821945
[TBL] [Abstract][Full Text] [Related]
17. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
Takimoto R; El-Deiry WS
Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
[TBL] [Abstract][Full Text] [Related]
18. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
19. Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.
Hu J; Ma X; Lindner DJ; Karra S; Hofmann ER; Reddy SP; Kalvakolanu DV
Oncogene; 2001 Jul; 20(31):4235-48. PubMed ID: 11464290
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional analysis and pap1-dependence of the unique gene encoding thioredoxin reductase from the fission yeast.
Kang HJ; Hong SM; Kim BC; Kim K; Park EH; Lim CJ
J Microbiol; 2006 Feb; 44(1):35-41. PubMed ID: 16554715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
